top of page
iNSPIRE Design2_edited.png

Why Medical Device Prototypes Fail During Manufacturing Scale-Up

  • Kunal Bijlani
  • 2 days ago
  • 5 min read

A medical device prototype working successfully in a lab is an exciting milestone.


But in medtech, a successful prototype and a scalable product are two very different things.


This is where many teams face an uncomfortable reality: the product that performed well during testing suddenly begins struggling once manufacturing enters the picture.


Dimensions behave differently. Assembly takes longer than expected. Components stop fitting consistently. Materials react differently during repeated use. A device that worked perfectly 20 times during testing becomes unreliable across 2,000 units.


And suddenly, timelines begin slipping.


According to industry estimates, redesigns discovered after verification or validation can delay commercialization timelines by anywhere between 3–9 months depending on product complexity and regulatory impact. Studies also suggest that nearly 70–80% of product lifecycle costs are influenced during the design phase itself, long before manufacturing begins.


The challenge is simple:

A prototype is built to prove functionality.

Manufacturing is built to prove consistency.

And consistency is significantly harder.


The Prototype Environment Is Controlled. Manufacturing Is Not.


Most prototypes are developed under highly controlled conditions:

  • Small Quantities

  • Limited Users

  • Controlled Assembly

  • Short Testing Cycles

  • Closely Monitored Environments


Manufacturing environments operate very differently.


Now the product must:

  • Be Built Repeatedly

  • Be Assembled By Multiple Operators

  • Handle Production Variation

  • Survive Shipping & Handling

  • Maintain Consistent Performance Across Thousands Of Units


A product working successfully once does not automatically mean it will work consistently across 10,000 units.


This is one reason why manufacturing scale-up exposes engineering problems prototypes often hide.


Small Variations Become Expensive At Scale


In medical devices, even minor dimensional changes can create major downstream impact.


A 1–2 mm spacing adjustment inside a compact enclosure may affect:

  • Wiring Accessibility

  • Thermal Management

  • Assembly Sequence

  • Structural Stability

  • Servicing Access


Similarly, a small tolerance variation may:

  • Affect Sensor Alignment

  • Increase Assembly Time

  • Create Fitment Issues

  • Reduce Reliability


At prototype stage, engineers often manually compensate for small inconsistencies.

At manufacturing scale, manual correction becomes operationally expensive.

Imagine an additional 30 seconds required during assembly.

Across:

  • 10,000 Units

  • Multiple Operators

  • Repeated Production Cycles


That small inefficiency becomes a major production bottleneck.


This is why Design for Manufacturing (DFM) becomes critical much earlier than many teams expect.


According to manufacturing studies, assembly simplification alone can reduce production costs by 20–50% depending on product complexity.


Material Selection Changes Everything


Material behaviour during prototyping and mass production can differ significantly.


A material that performs well during:

  • Initial Testing

  • Limited Usage

  • Controlled Environments


May behave very differently under:

  • Repeated Sterilization

  • Continuous Handling

  • Manufacturing Stress

  • Long-Term Wear

  • High-Volume Production


We’ve seen situations where:

  • Plastic Components Warped During Production

  • Surface Finishes Became Inconsistent

  • Repeated Usage Exposed Ergonomic Issues

  • Thermal Expansion Affected Alignment


And because medical devices operate under stricter reliability expectations, even small inconsistencies become important.


Especially in products involving:

  • Moving Mechanisms

  • Sensors

  • Compact Assemblies

  • Electronics Integration

  • Disposable Components


The challenge is not just selecting a material that works technically.


It’s selecting one that remains manufacturable, scalable, reliable, and commercially viable at production volume.

  • Assembly Decisions Change

And these changes may require additional engineering modifications.

This interconnectedness is what makes medical device scale-up uniquely complex.


Manufacturing Reveals Workflow Problems Too



Some products fail during scale-up not because of engineering limitations, but because manufacturing workflows themselves become impractical.


A prototype may:

  • Require Manual Adjustment

  • Depend On Skilled Handling

  • Need Delicate Assembly

  • Use Difficult-To-Source Components


These approaches may work for 5 units.

They become risky at 5,000.


Manufacturing teams begin evaluating:

  • Assembly Speed

  • Repeatability

  • Production Yield

  • Error Rates

  • Supplier Stability


This is where engineering decisions quickly become operational and commercial decisions.


For example, reducing even ₹50 per unit may seem insignificant during prototyping.

Across 50,000 units, that becomes ₹25 lakh.

Suddenly:

  • Material Decisions Change

  • Tooling Decisions Change

  • Supplier Decisions Change


Why Usability Problems Often Appear Late


One of the biggest misconceptions in medtech is that usability is already “solved” once the prototype works.


In reality, usability problems often become more visible during scale-up.

Especially when products move from:

  • Controlled Testing to

  • High-Frequency Clinical Usage

A device used occasionally may tolerate small friction points.

A device used 200+ times daily cannot.


We’ve seen products struggle because:

  • Cleaning Took Too Long

  • Setup Interrupted Workflow

  • Repeated Handling Created Fatigue

  • Grip Became Uncomfortable During Long Shifts


These issues may not appear immediately during limited prototype testing.

But inside real healthcare environments handling 150–300 patient interactions daily, small inefficiencies compound rapidly.


Research shows clinicians can spend nearly 15–20% of their workflow time interacting with medical equipment, interfaces, and setup processes. Even small usability inefficiencies therefore have large operational impact over time.


This is one reason why hospital adoption depends heavily on operational usability, not just technical capability.


Validation Delays Often Begin Much Earlier


Many teams assume validation is where delays begin.


In reality, validation often exposes decisions that should have been addressed much earlier.

Common examples include:

  • Workflow Assumptions

  • Manufacturability Gaps

  • Incomplete Documentation

  • Supplier Dependency Issues

  • Usability Oversights


By validation stage:

  • Tooling May Already Exist

  • Vendors Are Already Coordinated

  • Timelines Are Committed

  • Testing Plans Are Active

Which means even small corrections become expensive.


A single redesign can now trigger:

  • Repeat Testing

  • Documentation Rework

  • Additional Validation

  • Manufacturing Delays


And unlike software, hardware redesigns rarely stay isolated.

One correction often affects multiple interconnected systems simultaneously.

According to FDA-related industry estimates, design changes introduced late in medical device development can increase project costs by 30–40% or more because of cascading verification, documentation, and validation requirements.


The Most Successful Products Think About Manufacturing Early


One common pattern across scalable medical devices is this:


Manufacturing considerations are introduced much earlier in development.

Not after engineering.

During engineering.

This includes:

  • DFM Thinking

  • Assembly Planning

  • Material Scalability

  • Workflow Testing

  • Supplier Feasibility

  • Usability Evaluation


The goal is not just building a functional prototype.

The goal is building something that can survive real-world manufacturing, usage, and scaling pressures.

Because in medtech, the distance between: “A Working Prototype” and “A Scalable Product” is much larger than most teams initially expect.


Conclusion


A successful prototype is an important milestone.

But it is not proof that a product is ready for manufacturing scale-up.


Medical device commercialization introduces:

  • Production Complexity

  • Workflow Reality

  • Usability Pressure

  • Supply Chain Constraints

  • Validation Dependencies

  • Manufacturing Variability


And this is where many products face their toughest engineering challenges.

The most effective medical device teams do not wait until manufacturing begins to think about scale.


They designed it much earlier.


If you're currently building a medical device and evaluating the transition from prototype to production, early engineering and manufacturability discussions can prevent expensive redesign cycles later. At Inspire Design, we work with teams across product development, prototyping, mechanical design, and Design for Manufacturing to help products move more smoothly from concept to scalable production.


Schedule a call with our team to walk through your requirements and understand the most practical way to move forward.


 
 
 

Comments


bottom of page